Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > APP and ABI Complete Merger

April 19th, 2006

APP and ABI Complete Merger

Abstract:
American Pharmaceutical Partners, Inc. (NASDAQ:APPX) (APP), a specialty injectable pharmaceutical company, and its parent company American BioScience, Inc. (ABI), a biotechnology company, today announced that the merger between the two companies has been completed. The combined company is named Abraxis BioScience, Inc. (Abraxis) and its common stock will trade as of April 19 on the Nasdaq National Market under the new ticker symbol "ABBI."

Source:
pharmalive.com

Bookmark:

Related News Press

Nanomedicine

Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013

Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013

Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013

Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013

Announcements

Penn engineers' nanoantennas improve infrared sensing May 20th, 2013

Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013

Kinks and curves at the nanoscale: New research shows 'perfect twin boundaries' are not so perfect May 20th, 2013

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013